Sanguinaria canadensis: Traditional medicine, phytochemical composition, biological activities and current uses

International Journal of Molecular Sciences

Volumn 17, Issue 9, 2016, Pages

  Croaker, Andrew ^a   King, Graham J ^a   Pyne, John H ^b   Anoopkumar Dukie, Shailendra ^c   Liu, Lei ^a  

^a SOUTHERN CROSS UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Alkaloid; Black salve; Bloodroot; Escharotic; Herbal; Sanguinaria canadensis; Sanguinarine; Skin cancer

Indexed keywords

ALKALOID; ALLOCRYPTOPINE; BENZOPHENANTHRIDINE DERIVATIVE; CHELERYTHRINE; CHELILUTINE; CHELIRUBINE; PLANT EXTRACT; PROTOPINE; SANGUILUTINE; SANGUINARIA CANADENSIS EXTRACT; SANGUINARINE; SANGUIRUBINE; UNCLASSIFIED DRUG; ZEEL; ANTINEOPLASTIC AGENT;

ANIMAL FOOD; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHRITIS; BIOLOGICAL ACTIVITY; CANCER RADIOTHERAPY; CARDIOVASCULAR EFFECT; CHEMICAL COMPOSITION; CHEMOSURGERY; COLUMN CHROMATOGRAPHY; DRUG EFFICACY; DRUG SAFETY; GINGIVA BLEEDING; GINGIVITIS; HISTOLOGY; HUMAN; MELANOMA; MENOPAUSAL SYNDROME; NONHUMAN; PHYTOCHEMISTRY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SANGUINARIA; SANGUINARIA CANADENSIS; SKIN CANCER; TOOTH PLAQUE; TRADITIONAL MEDICINE; VETERINARY MEDICINE; ANIMAL; CHEMISTRY; PHYTOTHERAPY; PROCEDURES;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BENZOPHENANTHRIDINES; HUMANS; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT EXTRACTS; SANGUINARIA;

EID: 84984846134     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17091414     Document Type: Review

References (296)

1. Fabricant, D.S.; Farnsworth, N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001, 109, 69-75
2. Vogel, V.J. American Indian Medicine; University of Oklahoma Press: Norman, OK, USA, 2013.
3. Mazzio, E.A.; Soliman, K.F. In vitro screening for the tumoricidal properties of international medicinal herbs. Phytother. Res. 2009, 23, 385-398
4. Slavik, J.; Slavikova, L. Alkaloide der mohngewächse (papaveraceae) XVII. Über neue alkaloide aus Sanguinaria canadensis L. Collect. Czechoslov. Chem. Commun. 1960, 25, 1667-1675
5. Damm, D.D.; Fantasia, J.E. White patch of maxillary vestibule. Sanguinarine-associated leukoplakia. Gen. Dent. 2002, 50, 466
6. Lu, J.J.; Bao, J.L.; Chen, X.P.; Huang, M.; Wang, Y.T. Alkaloids isolated from natural herbs as the anticancer agents. Evid. Based Complement. Altern. Med. 2012, 2012, 485042
7. Bambagiotti-Alberti, M.; Pinzauti, S.; Moneti, G.; Gratteri, P.; Coran, S.A.; Vincieri, F.F. Characterization of Sanguinaria canadensis L. Fluid extract by fab mass spectrometry. J. Pharm. Biomed. Anal. 1991, 9, 1083-1087
8. Malikova, J.; Zdarilova, A.; Hlobilkova, A. Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czechoslov. 2006, 150, 5-12
9. Miao, F.; Yang, X.J.; Zhou, L.; Hu, H.J.; Zheng, F.; Ding, X.D.; Sun, D.M.; Zhou, C.D.; Sun, W. Structural modification of sanguinarine and chelerythrine and their antibacterial activity. Nat. Prod. Res. 2011, 25, 863-875
10. Mackraj, I.; Govender, T.; Gathiram, P. Sanguinarine. Cardiovasc. Ther. 2008, 26, 75-83
11. Wink, M.; Schmeller, T.; Latz-Bruning, B. Modes of action of allelochemical alkaloids: Interaction with neuroreceptors, DNA, and other molecular targets. J. Chem. Ecol. 1998, 24, 1881-1937
12. Saeed, S.; Gilani, A.; Majoo, R.; Shah, B. Anti-thrombotic and anti-inflammatory activities of protopine. Pharmacol. Res. 1997, 36, 1-7
13. Kosina, P.; Walterova, D.; Ulrichova, J.; Lichnovsky, V.; Stiborova, M.; Rydlova, H.; Vicar, J.; Krecman, V.; Brabec, M.J.; Simanek, V. Sanguinarine and chelerythrine: Assessment of safety on pigs in ninety days feeding experiment. Food Chem. Toxicol. 2004, 42, 85-91
14. Hannah, J.J.; Johnson, J.D.; Kuftinec, M.M. Long-term clinical evaluation of toothpaste and oral rinse containing sanguinaria extract in controlling plaque, gingival inflammation, and sulcular bleeding during orthodontic treatment. Am. J. Orthod. Dentofac. Orthop. 1989, 96, 199-207
15. Jäggi, R.; Würgler, U.; Grandjean, F.; Weiser, M. Dual inhibition of 5-lipoxygenase/cyclooxygenase by a reconstituted homeopathic remedy; possible explanation for clinical efficacy and favourable gastrointestinal tolerability. Inflamm. Res. 2004, 53, 150-157
16. Hou, J.L.; Brewer, J.D. Black salve and bloodroot extract in dermatologic conditions. Cutis 2015, 95, 309-311
17. Vlachojannis, C.; Magora, F.; Chrubasik, S. Rise and fall of oral health products with canadian bloodroot extract. Phytother. Res. 2012, 26, 1423-1426
18. Eastman, K.L.; McFarland, L.V.; Raugi, G.J. A review of topical corrosive black salve. J. Altern. Complement. Med. 2014, 20, 284-289
19. Laub, D.R., Jr. Death from metastatic basal cell carcinoma: Herbal remedy or just unlucky? J. Plast. Reconstr. Aesth. Surg. 2008, 61, 846-848
20. Salmore, A.K.; Hunter, M.D. Environmental and genotypic influences on isoquinoline alkaloid content in Sanguinaria canadensis. J. Chem. Ecol. 2001, 27, 1729-1747
21. Bennett, B.C.; Bell, C.R.; Boulware, R.T. Geographic variation in alkaloid content of Sanguinaria canadensis (Papaveraceae). Rhodora 1990, 92, 57-69.
22. Gaziano, R.; Moroni, G.; Buè, C.; Miele, M.T.; Sinibaldi-Vallebona, P.; Pica, F. Antitumor effects of the benzophenanthridine alkaloid sanguinarine: Evidence and perspectives. World J. Gastrointest. Oncol. 2016, 8, 30-39
23. Senchina, D.S.; Flinn, G.N.; McCann, D.A.; Kohut, M.L.; Shearn, C.T. Bloodroot (Sanguinaria canadensis L., papaveraceae) enhances proliferation and cytokine production by human peripheral blood mononuclear cells in an in vitro model. J. Herbs Spices Med. Plants 2009, 15, 45-65
24. Debiton, E.; Madelmont, J.C.; Legault, J.; Barthomeuf, C. Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion. Cancer Chemother. Pharmacol. 2003, 51, 474-482
25. Karp, J.M.; Rodrigo, K.A.; Pei, P.; Pavlick, M.D.; Andersen, J.D.; McTigue, D.J.; Fields, H.W.; Mallery, S.R. Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues. Toxicol. Lett. 2005, 158, 50-60
26. Keith, C.T.; Borisy, A.A.; Stockwell, B.R. Multicomponent therapeutics for networked systems. Nat. Rev. Drug Discov. 2005, 4, 71-78
27. Ernst, W.R. The genera of papaveraceae and fumariaceae in the Southeastern United States. J. Arnold Arbor. 1962, 43, 315-343.
28. Nieuwland, J.A. Notes on the seedlings of bloodroot. Am. Midl. Nat. 1910, 1, 199-203
29. Parkinson, J. Theatrum Botanicum: The Theater of Plants, or, an Herball of a Large Extent; Tho. Cotes: London, UK, 1640; pp. 324-334.
30. Plukenet, L. Almagestum Botanicum; Sumptibus Auctoris: London, UK, 1696; pp. 279-280.
31. Felter, H.W.; Lloyd, J.U. Sanguinaria (u.S.P.)-Sanguinaria. In King’s American Dispensatory; Ohio Valley Co.: Cincinnatti, OH, USA, 1898; pp. 1708-1714.
32. Dillen, J.J. Hortus Elthamensis seu Plantarum Rariorum quas in Horto suo Elthami in Cantio, Coluit… Jacobus Sherard,… Delineationes et Descriptiones… Auctore Johanne Jacobo Dillenio md; Sumptibus Auctoris: London, UK, 1732; pp. 334-336.
33. Linnaeus, C. Species Plantarum; Laurentii Salvii: Stockholm, Sweden, 1753; p.
34. Rafinesque, C.S. Manual of the Medical Botany of the United States of North America; Atkinson & Alexander: Philadelphia, PA, USA, 1830; Volume 2, pp. 78-81.
35. Lyon, D.L. Bee pollination of facultatively xenogamous Sanguinaria canadensis L. Bull. Torrey Bot. Club 1992, 119, 368-375
36. Beattie, A.J.; Culver, D.C. The guild of myrmecochores in the herbaceous Flora of West Virginia forests. Ecology 1981, 62, 107-115
37. Pudlo, R.J.; Beattie, A.J.; Culver, D.C. Population consequences of changes in an ant-seed mutualism in Sanguinaria canadensis. Oecologia 1980, 46, 32-37
38. Gomez, C.; Espadaler, X. Myrmecochorous dispersal distances: A world survey. J. Biogeogr. 1998, 25, 573-580
39. Lobstein, M.B.; Rockwood, L.L. Influence of elaiosome removal on germination in five ant-dispersed plant species. Va. J. Sci. 1993, 44, 59-72.
40. Porter, S.D.; Savignano, D.A. Invasion of polygyne fire ants decimates native ants and disrupts arthropod community. Ecology 1990, 71, 2095-2106
41. Zettler, J.A.; Spira, T.P.; Allen, C.R. Ant-seed mutualisms: Can red imported fire ants sour the relationship? Biol. Conserv. 2001, 101, 249-253
42. Heithaus, E.R. Seed predation by rodents on three ant-dispersed plants. Ecology 1981, 136-145
43. Grieve, M.; Leyel, C.F. A Modern Herbal the Medicinal Culinary Cosmetic and Economic Properties Cultivation and Folk-Lore of Herbs, Grases Fungi, Shrubs & Trees with All Their Modern Uses; Harcourt, Brace & Co.: New York, NY, USA, 1931.
44. Fern, K. Plants for a Future: The Species Database. Available online: http://www.ibiblio.org/pfaf/database/latinS.html (accessed on 8 May 2016).
45. Marino, P.C.; Eisenberg, R.M.; Cornell, H.V. Influence of sunlight and soil nutrients on clonal growth and sexual reproduction of the understory perennial herb Sanguinaria canadensis L. J. Torrey Bot. Soc. 1997, 219-227
46. Boothroyd-Roberts, K.; Gagnon, D.; Truax, B. Hybrid poplar plantations are suitable habitat for reintroduced forest herbs with conservation status. SpringerPlus 2013, 2, 507
47. Salmore, A.K.; Hunter, M.D. Elevational trends in defense chemistry, vegetation, and reproduction in Sanguinaria canadensis. J. Chem. Ecol. 2001, 27, 1713-1727
48. Erichsen-Brown, C. Medicinal and other Uses of North American Plants: A Historical Survey with Special Reference to the Eastern Indian Tribes; Courier Corporation: North Chelmsford, MA, USA, 2013.
49. Chamberlain, A.F. Algonkian words in american english: A study in the contact of the white man and the Indian. J. Am. Folk. 1902, 15, 240-267
50. Strachey, W. The Historie of Travaile into Virginia Britannia; Hakluyt Society: London, UK, 1849; p.
51. Gilmore, M.R. Uses of Plants by the Indians of the Missouri River Region; University of Nebraska Press: Lincoln, NE, USA, 1991; pp. 44-45.
52. Herrick, J.W.; Snow, D.R. Iroquois Medical Botany; Syracuse University Press: Syracuse, NY, USA, 1995; pp. 127-128.
53. Smith, H.H. Ethnobotany of the Ojibwe Indians; Order of the Board of Trustees: Milwaukee, WI, USA, 1932; pp. 377-378.
54. Smith, H.H. Ethnobotany of the Forest Potawatomi Indians; AMS Press Inc.: New York, NY, USA, 1933; pp. 175-326.
55. Tantaquidgeon, G. A Study of Delaware Indian Medicine Practice and Folk Beliefs; Commonwealth of Pennsylvania, Departmet of Public Instruction, Pennsylvania Historical Commission: Harrisburg, PA, USA, 1942; p.
56. Speck, F.G. Medicine practices of the Northeastern Algonquians; International Congress of Americanists: Washington, DC, USA, 1917; p.
57. Densmore, F. Uses of plants by the Chippewa Indians. Bur. Am. Ethnol. Bull. 1928, 44, 275-397.
58. Mechling, W.H. The malecite Indians, with notes on the Micmacs (concluded). Anthropologica 1959, 8, 161-274
59. Rousseau, J. Ethnobotanique abénaklse. Arch. Folk. 1947, 11, 145-182.
60. Sollenberger, R.R. Rappahannock field notes. Am. Philos. Soc. 1940.
61. Smith, H.H. Ethnobotany of the Meskwaki Indians; Public Museum of the City of Milwaukee: Milwaukee, WI, USA, 1928.
62. Chandler, R.F. Vindication of maritime Indian herbal remedies. J. Ethnopharmacol. 1983, 9, 323-327
63. Hunter, J.D. Manners and Customs of several Indian Tribes Located West of the Mississippi: Including Some Account of the Soil, Climate, and Vegetable Productions, and the Indian Materia Medica: To Which Is Prefixed the History of the Author’s Life during a Residence of Several Years among Them; Ross & Haines: Minneapolis, PA, USA, 1823; p.
64. Krochmal, A. Medicinal plants and Appalachia. Econ. Bot. 1968, 22, 332-337
65. Downey, W. An Investigation of the Properties of the Sanguinaria canadensis; or Puccoon; Eaken & Mecum.: Philadelphia, PA, USA, 1803; pp. 23-25.
66. Gibb, G.D. The Sanguinaria canadensis: Its natural history, properties, and medical uses. BMJ 1860, 4, 104-107
67. Allen, J.A. Remarks on the treatment of tracheitis, or croup. Boston Med. Surg. J. 1845, 33, 389-392
68. Eberle, J. A Treatise of the Materia Medica and Therapeutics; Grigg & Elliot: Philadelphia, PA, USA, 1834; Volume 2, pp. 73-76.
69. Leonard, J. On the use of Sanguinaria. Boston Med. Surg. J. 1845, 32, 457-459
70. Leopold, D. A history of rhinology in North America. Otolaryngol. Head Neck Surg. 1996, 115, 283-297
71. Barton, W.P.C. Vegetable Materia Medica of the United States, or, Medical Botany: Containing a Botanical, General, and Medical History, of Medicinal Plants Indigenous to the United States: Illustrated by Colored Engravings, Made after Original Drawings from Nature, Done by the Author; M. Carey & Son: Philadelphia, PA, USA, 1817; pp. 30-42.
72. Thatcher, J. The American New Dispensatory, 2nd ed.; Thomas B. Wait & Co. and C. Williams: Boston, MA, USA, 1813; pp. 201-204.
73. Bartholow, R. A Practical Treatise on Materia Medica and Therapeutics; D. Appleton: New York, NY, USA, 1888; pp. 359-361.
74. William, T. Sanguinarine and its salts: On the medicinal powers of sanguinarine and its salts. Boston Med. Surg. J. 1832, 6, 245-248
75. Mackentosh, J.; Holderwell, S. Receipts for the Cure of Most Diseases to the Human Family; U.S. National Library of Medicine: New York, NY, USA, 1827; p. 9.
76. Smith, D.B. On Sanguinaria canadensis. Boston Med. Surg. J. 1832, 5, 393-395
77. Ellingwood, F.; Lloyd, J.U. American Materia Medica, Therapeutics and Pharmacognosy: Developing the Latest Acquired Knowledge of Drugs, and Especially of the Direct Action of Single Drugs upon Exact Conditions of Disease, With Especial Reference to the Therapeutics of the Plant Drugs of the Americas; Ellingwoods’ Therapeutist: Evanston, IL, USA, 1915; pp. 386-387.
78. Stillé, A. Therapeutics and Materia Medica; Blanchard and Lea: Philadelphia, PA, USA, 1874; Volume 2, pp. 454-457.
79. Cook, W. The Physiomedical Dispensatory; Wm. H. Cook: Cincinnati, OH, USA, 1869; pp. 466-467.
80. Beach, W. The American Practice of Medicine; Betts & Anstice: New York, NY, USA, 1833; Volume 2, pp. 259-261.
81. Fell, J.W. A Treatise on Cancer, and Its Treatment; John Churchill: London, UK, 1857; pp. 59-63.
82. Shaw, A.D.M.C.; Moore, C.H.; Henry, M. Editorial. West. Lancet Mon. J. Pract. Med. Surg. 1857, 18, 541-542.
83. Hooper, S.N.; Chandler, R.F. Herbal remedies of the maritime Indians: Phytosterols and triterpenes of 67 plants. J. Ethnopharmacol. 1984, 10, 181-194
84. Dana, J.F. An account of some experiments on the root of the Sanguinaria canadensis. N. Y. Med. Phys. J. 1827, 6, 218-222
85. Probst, Q.M. Beschreibung und Dartsellungsweise einiger bei der Analyse de Chelidonium majus neu aufgefundenen Stoffe. Justus Liebigs Ann. Chem. 1839, 29, 113
86. Konig, G. Über Papaveraceen-Alkaloïde. Arch. Pharm. 1893, 231, 177
87. Gadamer, J.; Stichel, A. Chelerythrine and sanguinarine. Arch. Pharm. 1924, 262, 488-500.
88. Slavik, J. Alkaloide der mohngewachse (Papaveraceae) X. Uber die nebenalkaloide des klatschmohns (Papaver rhoeas L.) und der herzblume (Dicentra spectabilis L.). Collect. Czech. Chem. Commun. 1959, 24, 2506-2515
89. Suchomelova, J.; Bochorakova, H.; Paulova, H.; Musil, P.; Taborska, E. HPLC quantification of seven quaternary benzo[c]phenanthridine alkaloids in six species of the family papaveraceae. J. Pharm. Biomed. Anal. 2007, 44, 283-287
90. Campbell, S.; Affolter, J.; Randle, W. Spatial and temporal distribution of the alkaloid sanguinarine in Sanguinaria canadensis L. (bloodroot). Econ. Bot. 2007, 61, 223-234
91. Homerberg, V.; Beringer, G. What is the proper time for the collection of sanguinaria? J. Am. Pharm. Assoc. 1913, 2, 1302
92. Farwell, O.A. The proper time to collect sanguinaria. Am. J. Pham. 1915, 87, 97-98.
93. Graf, T.N.; Levine, K.E.; Andrews, M.E.; Perlmutter, J.M.; Nielsen, S.J.; Davis, J.M.; Wani, M.C.; Oberlies, N.H. Variability in the yield of benzophenanthridine alkaloids in wildcrafted vs. cultivated bloodroot (Sanguinaria canadensis L.). J. Agric. Food Chem. 2007, 55, 1205-1211
94. Rho, D.; Chauret, N.; Laberge, N.; Archambault, J. Growth characteristics of Sanguinaria canadensis L. Cell suspensions and immobilized cultures for production of benzophenanthridine alkaloids. Appl. Microbiol. Biotechnol. 1992, 36, 611-617
95. Becci, P.J.; Schwartz, H.; Barnes, H.H.; Southard, G.L. Short-term toxicity studies of sanguinarine and of two alkaloid extracts of Sanguinaria canadensis L. J. Toxicol. Environ. Health 1987, 20, 199-208
96. Levin, D.A. Alkaloid-bearing plants: An ecogeographic perspective. Am. Nat. 1976, 110, 261-284
97. Jeanne, R.L. A latitudinal gradient in rates of ant predation. Ecology 1979, 60, 1211-1224
98. Levin, D.A. The toxicity of plant alkaloids: An ecogeographic perspective. Biochem. Syst. Ecol. 1978, 6, 61-76
99. Chandra, P.; Purohit, A. Berberine contents and alkaloid profile of berberis species from different altitudes. Biochem. Syst. Ecol. 1980, 8, 379-380
100. Carey, D.B.; Wink, M. Elevational variation of quinolizidine alkaloid contents in a lupine (Lupinus argenteus) of the Rocky Mountains. J. Chem. Ecol. 1994, 20, 849-857
101. Pencikova, K.; Urbanova, J.; Musil, P.; Taborska, E.; Gregorova, J. Seasonal variation of bioactive alkaloid contents in Macleaya microcarpa (Maxim.) Fedde. Molecules 2011, 16, 3391-3401
102. Arnason, J.; Guerin, B.; Kraml, M.; Mehta, B.; Redmond, R.; Scaiano, J. Phototoxic and photochemical properties of sanguinarine. Photochem. Photobiol. 1992, 55, 35-38
103. Maiti, M.; Nandi, R.; Chaudhuri, K. The effect of PH on the absorption and fluorescence-spectra of sanguinarine. Photochem. Photobiol. 1983, 38, 245-249
104. Jones, R.R.; Harkrader, R.J.; Southard, G.L. The effect of PH on sanguinarine iminium ion form. J. Nat. Prod. 1986, 49, 1109-1111
105. Bajaj, N.P.; McLean, M.J.; Waring, M.J.; Smekal, E. Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids. J. Mol. Recognit. 1990, 3, 48-54
106. Todor, I. The effect of the antineoplastic drug ukrain on the electrokinetic potential of malignant and normal cells. Int. J. Immunother. 2003, 19, 159-168.
107. Maiti, M.; Das, S.; Sen, A.; Das, A.; Kumar, G.S.; Nandi, R. Influence of DNA structures on the conversion of sanguinarine alkanolamine form to iminium form. J. Biomol. Struct. Dyn. 2002, 20, 455-464
108. Slaninova, I.; Slanina, J.; Taborska, E. Quaternary benzo[c]phenanthridine alkaloids-Novel cell permeant and red fluorescing DNA probes. Cytom. A 2007, 71, 700-708
109. Bai, L.P.; Zhao, Z.Z.; Cai, Z.; Jiang, Z.H. DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine. Bioorg. Med. Chem. 2006, 14, 5439-5445
110. Byrn, S.R.; Dolch, G.D. Analysis of binding of daunorubicin and doxorubicin to DNA using computerized curve-fitting procedures. J. Pharm. Sci. 1978, 67, 688-693
111. Messori, L.; Temperini, C.; Piccioli, F.; Animati, F.; Di Bugno, C.; Orioli, P. Solution chemistry and DNA binding properties of men 10755, a novel disaccharide analogue of doxorubicin. Bioorg. Med. Chem. 2001, 9, 1815-1825
112. Adhami, V.M.; Aziz, M.H.; Reagan-Shaw, S.R.; Nihal, M.; Mukhtar, H.; Ahmad, N. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol. Cancer Ther. 2004, 3, 933-940
113. Nitiss, J.L. Targeting DNA topoisomerase ii in cancer chemotherapy. Nat. Rev. Cancer 2009, 9, 338-350
114. Holy, J.; Lamont, G.; Perkins, E. Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine. BMC Cell Biol. 2006, 7, 13
115. Vos, S.M.; Tretter, E.M.; Schmidt, B.H.; Berger, J.M. All tangled up: How cells direct, manage and exploit topoisomerase function. Nat. Rev. Mol. Cell Biol. 2011, 12, 827-841
116. Yang, D.; Okamoto, K. Structural insights into G-quadruplexes: Towards new anticancer drugs. Future Med. Chem. 2010, 2, 619-646
117. Bai, L.P.; Hagihara, M.; Jiang, Z.H.; Nakatani, K. Ligand binding to tandem g quadruplexes from human telomeric DNA. ChemBioChem 2008, 9, 2583-2587
118. Wen, L.N.; Xie, M.X. Competitive binding assay for G-quadruplex DNA and sanguinarine based on room temperature phosphorescence of Mn-doped ZnS quantum dots. J. Photochem. Photobiol. A Chem. 2014, 279, 24-31
119. Cummaro, A.; Fotticchia, I.; Franceschin, M.; Giancola, C.; Petraccone, L. Binding properties of human telomeric quadruplex multimers: A new route for drug design. Biochimie 2011, 93, 1392-1400
120. Ji, X.; Sun, H.; Zhou, H.; Xiang, J.; Tang, Y.; Zhao, C. The interaction of telomeric DNA and c-myc22 G-quadruplex with 11 natural alkaloids. Nucleic Acid Ther. 2012, 22, 127-136
121. Lopus, M.; Panda, D. The benzophenanthridine alkaloid sanguinarine perturbs microtubule assembly dynamics through tubulin binding. A possible mechanism for its antiproliferative activity. FEBS J. 2006, 273, 2139-2150
122. Wolff, J.; Knipling, L. Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry 1993, 32, 13334-13339
123. Kinniburgh, A.J. A cis-acting transcription element of the c-myc gene can assume an H-DNA conformation. Nucleic Acids Res. 1989, 17, 7771-7778
124. Raghavan, S.C.; Chastain, P.; Lee, J.S.; Hegde, B.G.; Houston, S.; Langen, R.; Hsieh, C.-L.; Haworth, I.S.; Lieber, M.R. Evidence for a triplex DNA conformation at the Bcl-2 major breakpoint region of the t (14; 18) translocation. J. Biol. Chem. 2005, 280, 22749-22760
125. Nelson, L.D.; Bender, C.; Mannsperger, H.; Buergy, D.; Kambakamba, P.; Mudduluru, G.; Korf, U.; Hughes, D.; Van Dyke, M.W.; Allgayer, H. Triplex DNA-binding proteins are associated with clinical outcomes revealed by proteomic measurements in patients with colorectal cancer. Mol. Cancer 2012, 11, 38
126. Latimer, L.J.; Payton, N.; Forsyth, G.; Lee, J.S. The binding of analogues of coralyne and related heterocyclics to DNA triplexes. Biochem. Cell Biol. 1995, 73, 11-18
127. Das, S.; Kumar, G.S.; Ray, A.; Maiti, M. Spectroscopic and thermodynamic studies on the binding of sanguinarine and berberine to triple and double helical DNA and RNA structures. J. Biomol. Struct. Dyn. 2003, 20, 703-713
128. Das, S.; Kumar, G.S.; Maiti, M. Conversions of the left-handed form and the protonated form of DNA back to the bound right-handed form by sanguinarine and ethidium: A comparative study. Biophys. Chem. 1999, 76, 199-218
129. Rich, A. Speculation on the biological roles of left-handed Z-DNAa. Ann. N. Y. Acad. Sci. 1994, 726, 1-17
130. Selvi, B.R.; Pradhan, S.K.; Shandilya, J.; Das, C.; Sailaja, B.S.; Shankar, G.N.; Gadad, S.S.; Reddy, A.; Dasgupta, D.; Kundu, T.K. Sanguinarine interacts with chromatin, modulates epigenetic modifications, and transcription in the context of chromatin. Chem. Biol. 2009, 16, 203-216
131. Gilbert, P.L.; Graves, D.E.; Britt, M.; Chaires, J.B. Inhibition of the B to Z transition in poly (dGdC). Cntdot. Poly (dGdC) by covalent attachment of ethidium: Kinetic studies. Biochemistry 1991, 30, 10931-10937
132. Giri, P.; Kumar, G.S. Molecular aspects of small molecules-poly(A) interaction: An approach to RNA based drug design. Curr. Med. Chem. 2009, 16, 965-987
133. Chowdhury, S.R.; Islam, M.M.; Kumar, G.S. Binding of the anticancer alkaloid sanguinarine to double stranded rnas: Insights into the structural and energetics aspects. Mol. Biosyst. 2010, 6, 1265-1276
134. Singh, C.K.; Kaur, S.; George, J.; Nihal, M.; Hahn, M.C.P.; Scarlett, C.O.; Ahmad, N. Molecular signatures of sanguinarine in human pancreatic cancer cells: A large scale label-free comparative proteomics approach. Oncotarget 2015, 6, 10335-10348
135. Matkar, S.S.; Wrischnik, L.A.; Hellmann-Blumberg, U. Production of hydrogen peroxide and redox cycling can explain how sanguinarine and chelerythrine induce rapid apoptosis. Arch. Biochem. Biophys. 2008, 477, 43-52
136. Hussain, S.P.; Amstad, P.; He, P.; Robles, A.; Lupold, S.; Kaneko, I.; Ichimiya, M.; Sengupta, S.; Mechanic, L.; Okamura, S. P53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004, 64, 2350-2356
137. Vrba, J.; Hrbac, J.; Ulrichova, J.; Modriansky, M. Sanguinarine is a potent inhibitor of oxidative burst in DMSO-differentiated HL-60 cells by a non-redox mechanism. Chem. Biol. Interact. 2004, 147, 35-47
138. Slaninova, I.; Pencikova, K.; Urbanova, J.; Slanina, J.; Taborska, E. Antitumour activities of sanguinarine and related alkaloids. Phytochem. Rev. 2014, 13, 51-68
139. Gu, S.; Yang, X.-C.; Xiang, X.-Y.; Wu, Y.A.O.; Zhang, Y.U.; Yan, X.-Y.; Xue, Y.-N.; Sun, L.-K.; Shao, G.-G. Sanguinarine-induced apoptosis in lung adenocarcinoma cells is dependent on reactive oxygen species production and endoplasmic reticulum stress. Oncol. Rep. 2015, 34, 913-919
140. Malhotra, J.D.; Kaufman, R.J. The Endoplasmic Reticulum and the Unfolded Protein Response. Semin. Cell Dev. Biol. 2007, 18, 716-731
141. Malhotra, J.D.; Kaufman, R.J. Er stress and its functional link to mitochondria: Role in cell survival and death. Cold Spring Harb. Perspect. Biol. 2011, 3, a004424
142. Malhotra, J.D.; Kaufman, R.J. Endoplasmic reticulum stress and oxidative stress: A vicious cycle or a double-edged sword? Antioxid. Redox Signal. 2007, 9, 2277-2294
143. Sanchez-Lopez, E.; Zimmerman, T.; Gomez del Pulgar, T.; Moyer, M.P.; Lacal Sanjuan, J.C.; Cebrian, A. Choline kinase inhibition induces exacerbated endoplasmic reticulum stress and triggers apoptosis via chop in cancer cells. Cell Death Dis. 2013, 4, e933
144. Coffey, R.N.; Watson, R.W.G.; Hegarty, N.J.; O’Neill, A.; Gibbons, N.; Brady, H.R.; Fitzpatrick, J.M. Thiol-mediated apoptosis in prostate carcinoma cells. Cancer 2000, 88, 2092-2104
145. Hall, A. The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Investig. 1999, 29, 238-245
146. Kerbel, R.S. Tumor angiogenesis. N. Engl. J. Med. 2008, 358, 2039-2049
147. Kerbel, R.; Folkman, J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer 2002, 2, 727-739
148. Eun, J.P.; Koh, G.Y. Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochem. Biophys. Res. Commun. 2004, 317, 618-624
149. De Stefano, I.; Raspaglio, G.; Zannoni, G.F.; Travaglia, D.; Prisco, M.G.; Mosca, M.; Ferlini, C.; Scambia, G.; Gallo, D. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochem. Pharmacol. 2009, 78, 1374-1381
150. Malikova, J.; Zdarilova, A.; Hlobilkova, A.; Ulrichova, J. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine. Cell Biol. Toxicol. 2006, 22, 439-453
151. Chmura, S.J.; Dolan, M.E.; Cha, A.; Mauceri, H.J.; Kufe, D.W.; Weichselbaum, R.R. In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clin. Cancer Res. 2000, 6, 737-742
152. Yu, R.; Mandlekar, S.; Tan, T.-H.; Kong, A.-N.T. Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J. Biol. Chem. 2000, 275, 9612-9619
153. Chan, S.-L.; Lee, M.C.; Tan, K.O.; Yang, L.-K.; Lee, A.S.; Flotow, H.; Fu, N.Y.; Butler, M.S.; Soejarto, D.D.; Buss, A.D. Identification of Chelerythrine as an inhibitor of BclXL function. J. Biol. Chem. 2003, 278, 20453-20456
154. Medvetz, D.; Priolo, C.; Henske, E.P. Therapeutic targeting of cellular metabolism in cells with hyperactive mTORC1: A paradigm shift. Mol. Cancer Res. 2015, 13, 3-8
155. Slaninova, I.; Slunska, Z.; Sinkora, J.; Vlkova, M.; Taborska, E. Screening of minor benzo[c]phenanthridine alkaloids for antiproliferative and apoptotic activities. Pharm. Biol. 2007, 45, 131-139
156. Hammerova, J.; Uldrijan, S.; Taborska, E.; Slaninova, I. Benzo[c]phenanthridine alkaloids exhibit strong anti-proliferative activity in malignant melanoma cells regardless of their p53 status. J. Dermatol. Sci. 2011, 62, 22-35
157. Slunska, Z.; Gelnarova, E.; Hammerova, J.; Taborska, E.; Slaninova, I. Effect of quaternary benzo[c]phenanthridine alkaloids sanguilutine and chelilutine on normal and cancer cells. Toxicol. in Vitro 2010, 24, 697-706
158. Hammerova, J.; Uldrijan, S.; Taborska, E.; Vaculova, A.H.; Slaninova, I. Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine. Biol. Chem. 2012, 393, 647-658
159. Vandenabeele, P.; Galluzzi, L.; Berghe, T.V.; Kroemer, G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 2010, 11, 700-714
160. Xiao, C.; Yuan, Y.; Ding, Y.Z.; Jin, T.F.; Pei, G. Study on the alkaloids from the stem of zanthoxylum dissitum. Zhong Yao Cai 2011, 34, 551-553
161. He, K.; Gao, J.-L. Protopine inhibits heterotypic celladhesion in MDA-MB-231 cells through down-regulation of multi-adhesive factors. Afr. J. Tradit. Complement. Altern. Med. 2014, 11, 415-424
162. Chaturvedi, M.M.; Kumar, A.; Darnay, B.G.; Chainy, G.B.; Agarwal, S.; Aggarwal, B.B. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, Iκα phosphorylation, and degradation. J. Biol. Chem. 1997, 272, 30129-30134
163. Bernardo, P.H.; Wan, K.F.; Sivaraman, T.; Xu, J.; Moore, F.K.; Hung, A.W.; Mok, H.Y.K.; Yu, V.C.; Chai, C.L.L. Structure-activity relationship studies of phenanthridine-based Bcl-Xl inhibitors. J. Med. Chem. 2008, 51, 6699-6710
164. Yang, S.; Xiang, J.F.; Yang, Q.F.; Li, Q.A.; Zhou, Q.J.; Zhang, X.F.; Tang, Y.L.; Xu, G.Z. Formation of human telomeric G-quadruplex structures induced by the quaternary benzophenanthridine alkaloids: Sanguinarine, nitidine, and chelerythrine. Chin. J. Chem. 2010, 28, 771-780
165. Ahsan, H.; Reagan-Shaw, S.; Breur, J.; Ahmad, N. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett. 2007, 249, 198-208
166. Han, M.H.; Kim, S.O.; Kim, G.Y.; Kwon, T.K.; Choi, B.T.; Lee, W.H.; Choi, Y.H. Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt. Anticancer Drugs 2007, 18, 913-921
167. Hussain, A.R.; Al-Jomah, N.A.; Siraj, A.K.; Pulicat, M.S.; Al-Hussein, K.A.; Al-Kuraya, K.S.; Uddin, S. Up-regulation of death receptor 5 and bax translocation is necessary to induce apoptosis by sanguinarine in primary effusion lymphoma. Blood 2006, 108, 234B.
168. Ghosh, S.; Jana, J.; Kar, R.K.; Chatterjee, S.; Dasgupta, D. Plant alkaloid chelerythrine induced aggregation of human telomere sequence-A unique mode of association between a small molecule and a quadruplex. Biochemistry 2015, 54, 974-986
169. Barreto, M.C.; Pinto, R.E.; Arrabaca, J.D.; Pavao, M.L. Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. Toxicol. Lett. 2003, 146, 37-47
170. Thomas, A.G.; Rojas, C.; Tanega, C.; Shen, M.; Simeonov, A.; Boxer, M.B.; Auld, D.S.; Ferraris, D.V.; Tsukamoto, T.; Slusher, B.S. Kinetic characterization of ebselen, chelerythrine and apomorphine as glutaminase inhibitors. Biochem. Biophys. Res. Commun. 2013, 438, 243-248
171. Shemon, A.N.; Sluyter, R.; Conigrave, A.D.; Wiley, J.S. Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor. Br. J. Pharmacol. 2004, 142, 1015-1019
172. Tan, I.; Lai, J.; Yong, J.; Li, S.F.Y.; Leung, T. Chelerythrine perturbs lamellar actomyosin filaments by selective inhibition of myotonic dystrophy kinase-related Cdc42-binding kinase. FEBS Lett. 2011, 585, 1260-1268
173. Zhang, Z.-F.; Guo, Y.; Zhang, J.-B.; Wei, X.-H. Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and Bcl-2 family proteins in human hepatoma SMMC-7721 cell. Arch. Pharm. Res. 2011, 34, 791-800
174. Slaninová, I.; Táborská, E.; Bochořáková, H.; Slanina, J. Interaction of benzo[c]phenanthridine and protoberberine alkaloids with animal and yeast cells. Cell Biol. Toxicol. 2001, 17, 51-63
175. Xiao, X.; Liu, J.; Hu, J.; Zhu, X.; Yang, H.; Wang, C.; Zhang, Y. Protective effects of protopine on hydrogen peroxide-induced oxidative injury of PC12 cells via Ca2+ antagonism and antioxidant mechanisms. Eur. J. Pharmacol. 2008, 591, 21-27
176. Schmeller, T.; Latz-Brüning, B.; Wink, M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 1997, 44, 257-266
177. Caballero-George, C.; Vanderheyden, P.M.; Apers, S.; van den Heuvel, H.; Solis, P.N.; Gupta, M.P.; Claeys, M.; Pieters, L.; Vauquelin, G.; Vlietinck, A.J. Inhibitory activity on binding of specific ligands to the human angiotensin II AT1 and endothelin 1 ETA receptors: Bioactive benzo[c]phenanthridine alkaloids from the root of Bocconia frutescens. Planta Med. 2002, 68, 770-775
178. Caballero-George, C.; Vanderheyden, P.; Solis, P.; Pieters, L.; Shahat, A.; Gupta, M.; Vauquelin, G.; Vlietinck, A. Biological screening of selected medicinal panamanian plants by radioligand-binding techniques. Phytomedicine 2001, 8, 59-70
179. Caballero-George, C.; Vanderheyden, P.M.L.; Solis, P.N.; Gupta, M.P.; Pieters, L.; Vauquelin, G.; Vlietinck, A. In vitro effect of sanguinarine alkaloid on binding of [3H] candesartan to the human angiotensin AT1 receptor. Eur. J. Pharmacol. 2003, 458, 257-262
180. Li, B.; Wu, Q.; Shi, J.-S.; Sun, A.-S.; Huang, X.-N. Effects of protopine on intracellular calcium and the PKC activity of rat aorta smooth muscle. Sheng Li Xue Bao 2005, 57, 240-246
181. Seifen, E.; Adams, R.J.; Riemer, R.K. Sanguinarine: A positive inotropic alkaloid which inhibits cardiac Na+,K+-ATPase. Eur. J. Pharmacol. 1979, 60, 373-377
182. Song, L.S.; Ren, G.J.; Chen, Z.L.; Chen, Z.H.; Zhou, Z.N.; Cheng, H. Electrophysiological effects of protopine in cardiac myocytes: Inhibition of multiple cation channel currents. Br. J. Pharmacol. 2000, 129, 893-900
183. Li, Y.; Wang, S.; Liu, Y.; Li, Z.; Yang, X.; Wang, H.; Wen, Y.; Chen, Y. Effect of α-allocryptopine on transient outward potassium current in rabbit ventricular myocytes. Cardiology 2008, 111, 229-236
184. Akbarov, Z.S.; Aliev, K.; Sultanov, M.B. Comparative study of the anti-arrhythmic action of the alkaloid a-allocryptopine with quinidine. Dokl. Akad. Nauk Uzb. 1972, 29, 38.
185. Yamamoto, S.; Seta, K.; Morisco, C.; Vatner, S.F.; Sadoshima, J. Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in Cardiac myocytes. J. Mol. Cell. Cardiol. 2001, 33, 1829-1848
186. Bae, D.S.; Kim, Y.H.; Pan, C.-H.; Nho, C.W.; Samdan, J.; Yansan, J.; Lee, J.K. Protopine reduces the inflammatory activity of lipopolysaccharide-stimulated murine macrophages. BMB Rep. 2012, 45, 108
187. Niu, X.-F.; Zhou, P.; Li, W.-F.; Xu, H.-B. Effects of chelerythrine, a specific inhibitor of cyclooxygenase-2, on acute inflammation in mice. Fitoterapia 2011, 82, 620-625
188. Vavreckova, C.; Gawlik, I.; Muller, K. Benzophenanthridine alkaloids of chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Med. 1996, 62, 397-401
189. Siomboing, X.; Gressier, B.; Dine, T.; Brunet, C.; Luyckx, M.; Cazin, M.; Cazin, J.-C. Investigation of the inhibitory effects of chelerythrine chloride on the translocation of the protein kinase c βi, βii, ζ in human neutrophils. IL Farmaco 2001, 56, 859-865
190. Vrba, J.; Dvorak, Z.; Ulrichova, J.; Modriansky, M. Conventional protein kinase c isoenzymes undergo dephosphorylation in neutrophil-like HL-60 cells treated by chelerythrine or sanguinarine. Cell Biol. Toxicol. 2008, 24, 39-53
191. Whyte, M.; Meagher, L.C.; MacDermot, J.; Haslett, C. Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol. 1993, 150, 5124-5134
192. Haslett, C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin. Sci. 1992, 83, 639-648
193. Grigg, J.; Silverman, M.; Savill, J.; Sarraf, C.; Haslett, C. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 1991, 338, 720-722
194. Savill, J.; Smith, J.; Sarraf, C.; Ren, Y.; Abbott, F.; Rees, A. Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis. Kidney Int. 1992, 42, 924-936
195. Sweeney, J.F.; Nguyen, P.K.; Atkins, K.B.; Hinshaw, D.B. Chelerythrine chloride induces rapid polymorphonuclear leukocyte apoptosis through activation of caspase-3. Shock 2000, 13, 464-471
196. Albelda, S.M.; Smith, C.W.; Ward, P. Adhesion molecules and inflammatory injury. FASEB J. 1994, 8, 504-512
197. Tang, M.; Fiscus, L. Important roles for l-selectin and icam-1 in the development of allergic airway inflammation in asthma. Pulm. Pharmacol. Ther. 2001, 14, 203-210
198. Mukhopadhyay, S.; Malik, P.; Arora, S.K.; Mukherjee, T.K. Intercellular adhesion molecule-1 as a drug target in asthma and rhinitis. Respirology 2014, 19, 508-513
199. Yang, C.M.; Luo, S.F.; Hsieh, H.L.; Chi, P.L.; Lin, C.C.; Wu, C.C.; Hsiao, L.D. Interleukin-1β induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: Involvement of erk, JNK, AP-1, and NF-κB. J. Cell. Physiol. 2010, 224, 516-526
200. Van Kuijk, A.W.; Reinders-Blankert, P.; Smeets, T.J.; Dijkmans, B.A.; Tak, P.P. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: Implications for treatment. Ann. Rheum. Dis. 2006, 65, 1551-1557
201. Tanaka, S.; Sakata, Y.; Morimoto, K.; Tambe, Y.; Watanabe, Y.; Honda, G.; Tabata, M.; Oshima, T.; Masuda, T.; Umezawa, T. Influence of natural and synthetic compounds on cell surface expression of cell adhesion molecules, ICAM-1 and VCAM-1. Planta Med. 2001, 67, 108-113
202. Obiang-Obounou, B.W.; Kang, O.H.; Choi, J.G.; Keum, J.H.; Kim, S.B.; Mun, S.H.; Shin, D.W.; Kim, K.W.; Park, C.B.; Kim, Y.G.; et al. The mechanism of action of sanguinarine against methicillin-resistant staphylococcus aureus. J. Toxicol. Sci. 2011, 36, 277-283
203. Hamoud, R.; Reichling, J.; Wink, M. Synergistic antimicrobial activity of combinations of sanguinarine and edta with vancomycin against multidrug resistant bacteria. Drug Metab. Lett. 2014, 8, 119-128
204. Dzink, J.L.; Socransky, S.S. Comparative in vitro activity of sanguinarine against oral microbial isolates. Antimicrob. Agents Chemother. 1985, 27, 663-665
205. Graham, D.Y.; Fischbach, L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010, 59, 1143-1153
206. Mahady, G.B.; Pendland, S.L.; Stoia, A.; Chadwick, L.R. In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytother. Res. 2003, 17, 217-221
207. Newton, S.M.; Lau, C.; Gurcha, S.S.; Besra, G.S.; Wright, C.W. The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. J. Ethnopharmacol. 2002, 79, 57-67
208. Seubert, J.; Pohlke, R.; Loebich, F. Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia 1977, 33, 1036-1037
209. Ismail, M.; Botros, S.; Metwally, A.; William, S.; Farghally, A.; Tao, L.-F.; Day, T.A.; Bennett, J.L. Resistance to praziquantel: Direct evidence from schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 1999, 60, 932-935
210. Zhang, S.-M.; Coultas, K.A. Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis. Int. J. Parasitol. Drugs Drug Resist. 2013, 3, 28-34
211. Schär, F.; Trostdorf, U.; Giardina, F.; Khieu, V.; Muth, S.; Marti, H.; Vounatsou, P.; Odermatt, P. Strongyloides stercoralis: Global distribution and risk factors. PLoS Negl. Trop. Dis. 2013, 7, e2288
212. Segarra-Newnham, M. Manifestations, diagnosis, and treatment of strongyloides stercoralis infection. Ann. Pharmacother. 2007, 41, 1992-2001
213. Satou, T.; Koga, M.; Matsuhashi, R.; Koike, K.; Tada, I.; Nikaido, T. Assay of nematocidal activity of isoquinoline alkaloids using third-stage larvae of Strongyloides ratti and S. Venezuelensis. Vet. Parasitol. 2002, 104, 131-138
214. Kaewviyudth, S.; Chinabut, S. Five new species of Dactylogyrus (Monogenea) from cyprimd fishes in Thailand. Asian Fish. Sci. 1999, 12, 391-399.
215. Wang, G.X.; Zhou, Z.; Jiang, D.X.; Han, J.; Wang, J.F.; Zhao, L.W.; Li, J. In vivo anthelmintic activity of five alkaloids from Macleaya microcarpa (Maxim.) fedde against Dactylogyrus intermedius in Carassius auratus. Vet. Parasitol. 2010, 171, 305-313
216. Satou, T.; Akao, N.; Matsuhashi, R.; Koike, K.; Fujita, K.; Nikaido, T. Inhibitory effect of isoquinoline alkaloids on movement of second-stage larvae of Toxocara canis. Biol. Pharm. Bull. 2002, 25, 1651-1654
217. Cheng, T.J.; Goodsell, D.S.; Kan, C.C. Identification of sanguinarine as a novel HIV protease inhibitor from high-throughput screening of 2000 drugs and natural products with a cell-based assay. Lett. Drug Des. Discov. 2005, 2, 364-371
218. Orhan, I.; Özcelik, B.; Sener, B. Antiviral and Antimicrobial Evaluation of Some Heterocyclic Compounds from Turkish Plants; Springer: Berlin, Germany, 2007; Volume 11, pp. 303-323.
219. Wangchuk, P.; Bremner, J.B.; Rattanajak, R.; Kamchonwongpaisan, S. Antiplasmodial agents from the bhutanese medicinal plant Corydalis calliantha. Phytother. Res. 2010, 24, 481-485
220. Rosenkranz, V.; Wink, M. Alkaloids induce programmed cell death in bloodstream forms of trypanosomes (Trypanosoma b. brucei). Molecules 2008, 13, 2462-2473
221. Meng, F.; Zuo, G.; Hao, X.; Wang, G.; Xiao, H.; Zhang, J.; Xu, G. Antifungal activity of the benzo[c]phenanthridine alkaloids from Chelidonium majus Linn against resistant clinical yeast isolates. J. Ethnopharmacol. 2009, 125, 494-496
222. Pong Ng, Y.; Tsun Or, T.C.; Ip, N.Y. Plant alkaloids as drug leads for Alzheimer’s disease. Neurochem. Int. 2015, 89, 260-270.
223. Kim, S.R.; Hwang, S.Y.; Jang, Y.P.; Park, M.J.; Markelonis, G.J.; Oh, T.H.; Kim, Y.C. Protopine from corydalis ternata has anticholinesterase and antiamnesic activities. Planta Med. 1999, 65, 218-221
224. Kim, D.K.; Lee, K.T.; Baek, N.-I.; Kim, S.-H.; Park, H.W.; Lim, J.P.; Shin, T.Y.; Eom, D.O.; Yang, J.H.; Eun, J.S. Acetylcholinesterase inhibitors from the aerial parts of Corydalis speciosa. Arch. Pharm. Res. 2004, 27, 1127-1131
225. Sener, B.; Orhan, İ. Discovery of drug candidates from some turkish plants and conservation of biodiversity. Pure Appl. Chem. 2005, 77, 53-64
226. Zheng, W.; Qiu, L.; Wang, R.; Feng, X.; Han, Y.; Zhu, Y.; Chen, D.; Liu, Y.; Jin, L.; Li, Y. Selective targeting of PPARΓ by the natural product chelerythrine with a unique binding mode and improved antidiabetic potency. Sci. Rep. 2015, 5, 12222
227. Lee, K.H.; Huh, J.; Choi, M.; Yoon, S.Y.; Yang, S.; Hong, H.; Cho, S. Regulation of glutamate level in rat brain through activation of glutamate dehydrogenase by Corydalis ternata. Exp. Mol. Med. 2005, 37, 371-377
228. Xu, L.-F.; Chu, W.-J.; Qing, X.-Y.; Li, S.; Wang, X.-S.; Qing, G.-W.; Fei, J.; Guo, L.-H. Protopine inhibits serotonin transporter and noradrenaline transporter and has the antidepressant-like effect in mice models. Neuropharmacology 2006, 50, 934-940
229. Engel, R. Ueber Das Protopin. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1890, 27, 419-431
230. Goto, K.; Oda, R. Studies on the Alkaloids of Macleya cordata R. J. Pharm. Soc. Jpn. 1949, 69, 307
231. Abu-Ghalyun, Y.; Masalmeh, A.; Al-Khalil, S. Effects of allocryptopine, an alkaloid isolated from glaucium arabicum on rat isolated ileum and urinary bladder. Gen. Pharmacol. Vasc. Syst. 1997, 29, 621-623
232. Üstünes, L.; Laekeman, G.M.; Gözler, B.; Vlietinck, A.J.; Özer, A.; Herman, A.G. In vitro study of the anticholinergic and antihistaminic activities of protopine and some derivatives. J. Nat. Prod. 1988, 51, 1021-1022
233. Jeng, J.H.; Wu, H.L.; Lin, B.R.; Lan, W.H.; Chang, H.H.; Ho, Y.S.; Lee, P.H.; Wang, Y.J.; Wang, J.S.; Chen, Y.J.; et al. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and camp production. Atherosclerosis 2007, 191, 250-258
234. European Union. Ban on Antibiotics as Growth Promoters in Animal Feed Enters into Effect (1831/2003/ec); European Commission: Brussels, Belgium, 2005.
235. Roth, R.; Kirchgessner, M. Organic acids as feed additives for young pigs: Nutritional and gastrointestinal effects. J. Anim. Feed Sci. 1998, 7, 25-33.
236. Blank, R.; Muller-Siegwardt, B.; Wolffram, S. Sanguinarine does not influence availability or metabolism of tryptophan in pigs. Livest. Sci. 2010, 134, 24-26
237. Stiborova, M.; Vostalova, J.; Zdarilova, A.; Ulrichova, J.; Hudecek, J.; Tschirner, K.; Simanek, V. Macleaya cordata extract and sangrovit genotoxicity. Assessment in vivo. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czechoslov. 2008, 152, 35-39
238. Kantas, D.; Papatsiros, V.G.; Tassis, P.D.; Athanasiou, L.V.; Tzika, E.D. The effect of a natural feed additive (Macleaya cordata), containing sanguinarine, on the performance and health status of weaning pigs. Anim. Sci. J. 2015, 86, 92-98
239. Vieira, S.; Oyarzabal, O.; Freitas, D.; Berres, J.; Pena, J.; Torres, C.; Coneglian, J. Performance of broilers fed diets supplemented with sanguinarine-like alkaloids and organic acids. J. Appl. Poult. Res. 2008, 17, 128-133
240. Rawling, M.D.; Merrifield, D.L.; Davies, S.J. Preliminary assessment of dietary supplementation of sangrovit® on red tilapia (Oreochromis niloticus) growth performance and health. Aquaculture 2009, 294, 118-122
241. Pickler, L.; Beirão, B.C.; Hayashi, R.M.; Durau, J.F.; Lourenço, M.C.; Caron, L.F.; Santin, E. Effect of sanguinarine in drinking water on salmonella control and the expression of immune cells in peripheral blood and intestinal mucosa of broilers. J. Appl. Poult. Res. 2013, 22, 430-438
242. Robbins, R.C.; Artuso-Ponte, V.C.; Moeser, A.J.; Morrow, W.E.M.; Spears, J.W.; Gebreyes, W.A. Effects of quaternary benzo[c]phenanthridine alkaloids on growth performance, shedding of organisms, and gastrointestinal tract integrity in pigs inoculated with multidrug-resistant Salmonella spp.. Am. J. Vet. Res. 2013, 74, 1530-1535
243. Taylor, S.; Haldorson, G. A review of equine sarcoid. Equine Vet. Educ. 2013, 25, 210-216
244. Nogueira, S.A.; Torres, S.M.; Malone, E.D.; Diaz, S.F.; Jessen, C.; Gilbert, S. Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: A pilot study. Vet. Dermatol. 2006, 17, 259-265
245. Pettersson, C. Utvärtes Behandling av Sarkoider på häst Med Aldara tm Eller Xxterra tm. slu. Ph.D. Thesis, Swedish University of Agricultural Sciences, Uppsala, Sweden, 1 February 2008.
246. Wilford, S.; Woodward, E.; Dunkel, B. Owners’ perception of the efficacy of newmarket bloodroot ointment in treating equine sarcoids. Can. Vet. J. 2014, 55, 683-686
247. Childress, M.O.; Burgess, R.C.; Holland, C.H.; Gelb, H.R. Consequences of intratumoral injection of a herbal preparation containing blood root (Sanguinaria canadensis) extract in two dogs. J. Am. Vet. Med. Assoc. 2011, 239, 374-379
248. Karjalainen, K.; Kaivosoja, S.; Seppa, S.; Knuuttila, M. Effects of sanguinaria extract on leucocytes and fibroblasts. Proc. Finn.Dent. Soc. 1988, 84, 161-165
249. Damm, D.D.; Curran, A.; White, D.K.; Drummond, J.E. Leukoplakia of the maxillary vestibule-An association with viadent? Oral Surg. Oral Med. 1999, 87, 61-66
250. Weatherell, J.A.; Robinson, C.; Rathbone, M. The flow of saliva and its influence on the movement, deposition and removal of drugs administered to the oral cavity. Drugs Pharm. Sci. 1996, 74, 157-189.
251. Munro, I.C.; Delzell, E.S.; Nestmann, E.R.; Lynch, B.S. Viadent usage and oral leukoplakia: A spurious association. Regul. Toxicol. Pharmacol. 1999, 30, 182-196
252. Eversole, L.R.; Eversole, G.M.; Kopcik, J. Sanguinaria-associated oral leukoplakia: Comparison with other benign and dysplastic leukoplakic lesions. Oral Surg. Oral Med. 2000, 89, 455-464
253. Allen, C.L.; Loudon, J.; Mascarenhas, A.K. Sanguinaria-related leukoplakia: Epidemiologic and clinicopathologic features of a recently described entity. Gen. Dent. 2001, 49, 608-614
254. Eley, B.M. Antibacterial agents in the control of supragingival plaque-A review. Br. Dent. J. 1999, 186, 286-296
255. Jacobs, J.; Herman, P.; Heron, K.; Olsen, S.; Vaughters, L. Homeopathy for menopausal symptoms in breast cancer survivors: A preliminary randomized controlled trial. J. Altern. Complement. Med. 2005, 11, 21-27
256. Milazzo, S.; Russell, N.; Ernst, E. Efficacy of homeopathic therapy in cancer treatment. Eur. J. Cancer 2006, 42, 282-289
257. Bordet, M.F.; Colas, A.; Marijnen, P.; Masson, J.L.; Trichard, M. Treating hot flushes in menopausal women with homeopathic treatment-Results of an observational study. Homeopathy 2008, 97, 10-15
258. Hielm-Björkman, A.; Tulamo, R.-M.; Salonen, H.; Raekallio, M. Evaluating complementary therapies for canine osteoarthritis-Part II: A homeopathic combination preparation (zeel®). Evid. Based Complement. Altern. Med. 2009, 6, 465-471
259. Nahler, G.; Metelmann, H.; Sperber, H. Behandlung der gonarthrose mit zeel [r] comp.-ergebnisse einer randomisierten, kontrollierten klinischen pruefung im vergleich zu hyaluronsaeure. Orthop. Pract. 1996, 32, 354-359.
260. Oral Treatment of Arthritis of the Knee with Zeel® Comp. Available online: http://www.homotoxicology.net/Documents/Brochures/Zeel.pdf (accessed on 16 August 2016).
261. Birnesser, H.; Klein, P.; Weiser, M. A modern homeopathic medication works as well as COX 2 inhibitors. Der Allg. 2003, 25, 261-264.
262. Mohs, F.; Guyer, M. Pre-excisional fixation of tissues in the treatment of cancer in rats. Cancer Res. 1941, 1, 49-51.
263. Kimyai-Asadi, A.; Goldberg, L.H.; Jih, M.H. Accuracy of serial transverse cross-sections in detecting residual basal cell carcinoma at the surgical margins of an elliptical excision specimen. J. Am. Acad. Dermatol. 2005, 53, 468-473
264. Trost, L.B.; Bailin, P.L. History of mohs surgery. Dermatol. Clin. 2011, 29, 135-139
265. Mohs, F.E. Chemosurgery: A microscopically controlled method of cancer excision. Arch. Surg. 1941, 42, 279-295
266. Mohs, F.E.; Caruso, R. Chemosurgery and skin cancer. AORN J. 1971, 13, 89-97
267. Mohs, F.E. Chemosurgery: Microscopically controlled surgery for skin cancer-Past, present and future. J. Dermatol. Surg. Oncol. 1978, 4, 41-54
268. Mohs, F.E. Chemosurgery for skin cancer: Fixed tissue and fresh tissue techniques. Arch. Dermatol. 1976, 112, 211-215
269. Farrow, R.T. Odyssey of an American cancer specialist of a hundred years ago. Bull. Hist. Med. 1949, 23, 236-262.
270. Middlesex Hospital. Report of the Surgical Staff of the Middlesex Hospital to the Weekly Board of Governors upon the Treatment of Cancerous Diseases in the Hospital on the Plan Introduced by dr. Fell; John Churchill.: London, UK, 1857.
271. Journal of the American Medical Association. Bureau of investigation, comment on court opinion that internal cancer can be cured with medicine. JAMA 1951, 145, 252-253.
272. Hoxsey, H.M. You Don’t Have to Die; Milestone Books: New York, NY, USA, 1956.
273. Austin, S.; Baumgartner, E.; DeKadt, S. Long term follow-up of cancer patients using contreras, hoxsey and gerson therapies. J. Naturop. Med. 1995, 5, 74-76.
274. Richardson, M.A.; Russell, N.C.; Sanders, T.; Barrett, R.; Salveson, C. Assessment of outcomes at alternative medicine cancer clinics: A feasibility study. J. Altern. Complement. Med. 2001, 7, 19-32
275. Jellinek, N.; Maloney, M.E. Escharotic and other botanical agents for the treatment of skin cancer: A review. J. Am. Acad. Dermatol. 2005, 53, 487-495
276. Cansema & Escharotics FAQ 200 Constituents; FAQ 206 What are the Side Effects; FAQ 215 Can it Be Used to Treat Melanoma; FAQ 222 Success Rate with Skin Cancer. Available online: http://www.altcancer.com/faqcan.htm (accessed on 15 July 2016).
277. Earth Circle Creation. Available online: http://shop.earthcirclecreations.com/product_info.php?cPath=61&products_id=263 (accessed on 15 July 2016).
278. Ong, N.C.; Sham, E.; Adams, B.M. Use of unlicensed black salve for cutaneous malignancy. Med. J. Aust. 2014, 200, 314
279. McDaniel, S.; Goldman, G.D. Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. Arch. Dermatol. 2002, 138, 1593-1596
280. Cienki, J.J.; Zaret, L. An internet misadventure: Bloodroot salve toxicity. J. Altern. Complement. Med. 2010, 16, 1125-1127
281. Sivyer, G.W.; Rosendahl, C. Application of black salve to a thin melanoma that subsequently progressed to metastatic melanoma: A case study. Dermatol. Pract. Concept. 2014, 4, 77-80
282. Osswald, S.S.; Elston, D.M.; Farley, M.F.; Alberti, J.G.; Cordero, S.C.; Kalasinsky, V.F. Self-treatment of a basal cell carcinoma with “black and yellow salve”. J. Am. Acad. Dermatol. 2005, 53, 509-511
283. Hopkins, A.L.; Mason, J.S.; Overington, J.P. Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol. 2006, 16, 127-136
284. Hopkins, A.L. Network pharmacology: The next paradigm in drug discovery. Nat. Chem. Biol. 2008, 4, 682-690
285. Ahmad, N.; Gupta, S.; Husain, M.M.; Heiskanen, K.M.; Mukhtar, H. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin. Cancer Res. 2000, 6, 1524-1528
286. Krstin, S.; Peixoto, H.S.; Wink, M. Combinations of alkaloids affecting different molecular targets with the saponin digitonin can synergistically enhance trypanocidal activity against Trypanosoma brucei. Antimicrob. Agents Chemother. 2015, 59, 7011-7017
287. Kulp, M.; Bragina, O. Capillary electrophoretic study of the synergistic biological effects of alkaloids from Chelidonium majus l. In normal and cancer cells. Anal. Bioanal. Chem. 2013, 405, 3391-3397
288. Braakhuis, B.J.; Tabor, M.P.; Kummer, J.A.; Leemans, C.R.; Brakenhoff, R.H. A genetic explanation of slaughter’s concept of field cancerization evidence and clinical implications. Cancer Res. 2003, 63, 1727-1730
289. Ansari, K.M.; Das, M. Potentiation of tumour promotion by topical application of argemone oil/isolated sanguinarine alkaloid in a model of mouse skin carcinogenesis. Chem. Biol. Interact. 2010, 188, 591-597
290. Ahsan, H.; Reagan-Shaw, S.; Eggert, D.M.; Tan, T.C.; Afaq, F.; Mukhtar, H.; Ahmad, N. Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: Implications for prevention of skin cancer. Photochem. Photobiol. 2007, 83, 986-993
291. Reagan-Shaw, S.; Breur, J.; Ahmad, N. Enhancement of UVB radiation-mediated apoptosis by sanguinarine in hacat human immortalized keratinocytes. Mol. Cancer Ther. 2006, 5, 418-429
292. Gesler, W.M. Therapeutic landscapes: Medical issues in light of the new cultural geography. Soc. Sci. Med. 1992, 34, 735-746
293. Harris, P.; Cooper, K.; Relton, C.; Thomas, K. Prevalence of complementary and alternative medicine (CAM) use by the general population: A systematic review and update. Int. J. Clin. Pract. 2012, 66, 924-939
294. Bent, S. Herbal medicine in the united states: Review of efficacy, safety, and regulation. J. Gen. Intern. Med. 2008, 23, 854-859
295. Board, S. Botanical medicines-The need for new regulations. N. Engl. J. Med. 2002, 347, 2073-2076.
296. Coghlan, M.L.; Maker, G.; Crighton, E.; Haile, J.; Murray, D.C.; White, N.E.; Byard, R.W.; Bellgard, M.I.; Mullaney, I.; Trengove, R. Combined DNA, toxicological and heavy metal analyses provides an auditing toolkit to improve pharmacovigilance of traditional Chinese medicine (TCM). Sci. Rep. 2015, 5, 17475